Steris | STE - Sales Revenues


Steris reported $1.5B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
3M USD 6.58B 84M Sep/2026
Accuray USD 116.17M 14.63M Dec/2024
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.14B 300M Sep/2026
CONMED USD 335.6M 7.9M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Ecolab USD 4.69B 280M Sep/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Fortive USD 1.11B 10M Sep/2026
Getinge SEK 8.38B 1000K Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
J&J USD 25.4B 89M Sep/2026
Olympus JPY 240.4B 54.88B Jun/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Steris USD 1.5B 90M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026